Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

17-allylamino-17-demethoxygeldanamycin

EU orphan designation number: EU/3/04/247
Active ingredient: 17-allylamino-17-demethoxygeldanamycin
Indication: Treatment of multiple myeloma
Sponsor: Bristol-Myers Squibb International Corporation
Parc de l’Alliance, Avenue de Finlande 8, B-1420 Braine-l’Alleud, Belgium

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/12/2004 Centralised Orphan - Designation EMEA/OD/070/04 (2004)5562 corr of 21/12/2004
31/10/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/070/04/T/01 (2008)6531 of 29/10/2008
23/02/2011 Centralised Orphan - Removal of orphan designation from Community Register